Comparative Genomic Profiling of Refractory/Metastatic Penile and non-Penile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy

Metastatic penile squamous cell carcinoma (mPSCC) is an aggressive malignancy with limited treatment options. We compared the potential therapy impacting genomic alterations (GA) between mPSCC and non-penile cutaneous metastatic squamous cell carcinoma (mCSCC).

Source: The Journal of Urology - October 3, 2018 Category: Urology & Nephrology Authors: J.M. Jacob, E.K. Ferry, L.M. Gay, J.A. Elvin, J. Vergilio, S. Ramkissoon, E. Severson, A. Necchi, J.K. Killian, S.M. Ali, A.B. Schrock, Nick W. Liu, J. Chung, V.A. Miller, P.J. Stephens, A. Welsh, R.J. Corona, J.S. Ross, G. Bratslavsky Source Type: research